Lijian Liang
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Liver Disease and Transplantation 6
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 7
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 12
- Surgery top 10%
- Cholangiocarcinoma and Gallbladder Cancer Studies 18
- Organ Transplantation Techniques and Outcomes 7
-
- Gallbladder and Bile Duct Disorders 8
-
- Neuroendocrine Tumor Research Advances 6
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Lijian Liang
71 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Hepatology 407
- Cancer Research 325
- Oncology 489
- Surgery 512
- Pulmonary and Respiratory Medicine 338
Countries citing papers authored by Lijian Liang
This map shows the geographic impact of Lijian Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijian Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijian Liang more than expected).
Fields of papers citing papers by Lijian Liang
This network shows the impact of papers produced by Lijian Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijian Liang. The network helps show where Lijian Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lijian Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 2 | |
| 3 | 2020 | 29 | |
| 4 | 2020 | 8 | |
| 5 | 2016 | 33 | |
| 6 | 2016 | 27 | |
| 7 | 2015 | 41 | |
| 8 | 2015 | 4 | |
| 9 | 2014 | 28 | |
| 10 | 2014 | 45 | |
| 11 | 2014 | 3 | |
| 12 | 2014 | 31 | |
| 13 | 2014 | 39 | |
| 14 | Gene expression profile of MAPK signal pathway in a human hepatocellular carcinoma cell line sensitive to sorafenib | 2013 | 0 |
| 15 | 2013 | 12 | |
| 16 | 2013 | 12 | |
| 17 | 2012 | 0 | |
| 18 | 2009 | 6 | |
| 19 | 2007 | 8 | |
| 20 | 2003 | 35 |
About Lijian Liang
Lijian Liang is a scholar working on Hepatology, Cancer Research and Oncology, having authored 74 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Pancreatic and Hepatic Oncology Research (12 papers), Gallbladder and Bile Duct Disorders (8 papers), Organ Transplantation Techniques and Outcomes (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Liver Disease and Transplantation (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Hepatology (407 citations), Cancer Research (325 citations) and Oncology (489 citations). Lijian Liang has collaborated with scholars based in China, United States and France. Frequent co-authors include Baogang Peng, Shaoqiang Li, Jiaming Lai, Yunpeng Hua, Ming Kuang, Shunjun Fu, Xiaoyu Yin, Ming‐De Lu, Dongming Li and Shunli Shen. Their work appears in journals such as Molecular Cell, Annals of Surgery and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.